- Filed
- May 6, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 4, 2020 | 19.39M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 19.34M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 18.15M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $1.58M |
| Capex | Q1 2020 · Mar 31, 2019 | $3.55M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$9.29M |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | −$7.94M |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $14M |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $14.33M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $45.15M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $55.72M |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | $92.51M |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | $85.22M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $23.53M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $23.67M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $40.74M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $41.61M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $23.56M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $34.03M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $85.89M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $97.32M |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $3.43M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $3.45M |
| Rd Expense | Q1 2020 · Mar 31, 2020 | $7.76M |
| Rd Expense | Q1 2020 · Mar 31, 2019 | $5.97M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$11.55M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$9.34M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$11.43M |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$9.42M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $0 |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $8.09K |
| Revenue | Q1 2020 · Mar 31, 2020 | $0 |
| Revenue | Q1 2020 · Mar 31, 2019 | $49.27K |